Prestige Consumer Healthcare Inc. (PBH)
Chart Events
Performance Outlook
| Previous Close | 60.26 |
| Open | 60.26 |
| Bid | 60.08 x 800 |
| Ask | 60.22 x 1100 |
| Day's Range | 60.04 - 60.77 |
| 52 Week Range | 50.40 - 63.83 |
| Volume | |
| Avg. Volume | 277,760 |
| Market Cap | 3.007B |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | 14.80 |
| EPS (TTM) | 4.07 |
| Earnings Date | Aug 03, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Sep 27, 2018 |
| 1y Target Est | 66.40 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for PBH
Related Research
- Prestige Consumer Healthcare InPBH: Raising target price to $60.00PRESTIGE CONSUMER HEALTHCARE has an Investment Rating of HOLD; a target price of $60.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.RatingFair ValueEconomic Moat8 days agoArgus Research
- Simply Wall St.
Prestige Consumer Healthcare (NYSE:PBH) shareholders have earned a 23% CAGR over the last three years
One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger...
- Zacks
Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates
Prestige Brands (PBH) delivered earnings and revenue surprises of 2.25% and 3.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022
Company Exceeds Full-Year Earnings Outlook for Revenue, EPS, and Cash FlowRevenue of $266.9 Million in Q4 and $1,086.8 Million for Full-Year Fiscal 2022, up 12.3% and 15.2% versus Prior Year, respectivelyAdjusted Diluted EPS of $4.06 for Fiscal 2022, up 25.3% versus Prior YearNet Cash Provided by Operating Activities of $259.9 Million and Record Non-GAAP Free Cash Flow of $253.7 Million in Full-Year Fiscal 2022Initial Full-Year Fiscal 2023 Revenue Outlook of Approximately 3% to 4%Board of Direct
